Gary Lichtenstein, MD

University of Pennsylvania
Philadelphia, PA

Presentation(s):

• 34 - Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results from the Phase 3 QUASAR Induction Study

  Tuesday, October 24, 2023
  9:30 AM – 9:40 AM PT